WASHINGTON, Oct 17 (Reuters) - Company data for a mass-produced version of Genzyme Corp's Myozyme to treat Pompe disease raises questions over how well it works and whether more data is needed before ...
BOSTON, Nov 16 (Reuters) - Genzyme Corp , which is struggling through the most trying period in its history, said on Monday U.S. regulators will not approve its drug to treat Pompe disease, a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results